Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_assertion description "[These findings demonstrate that andrographolide suppresses the adhesion of gastric cancer cells which express high level sialyl Lewis(X) to human vascular endothelial cells by blocking E-selectin expression and, thus, may represent a candidate therapeutic agent for cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_assertion evidence source_evidence_literature NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_assertion SIO_000772 17695536 NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_assertion wasDerivedFrom befree-20140225 NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_assertion wasGeneratedBy ECO_0000203 NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP634800.RAu2m6Ys9pf1ZlKVhJtsZxwHELU3_6botylI6L21jyN-I130_provenance.